gabexate has been researched along with Cirrhoses, Experimental Liver in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Camostat mesilate was either added to cultured rat HSCs or administered orally to rats during porcine serum treatment, followed by overexpression of urokinase." | 1.31 | Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. ( Akita, K; Ikeda, K; Kaneda, K; Kawada, N; Kojima, S; Moriwaki, H; Okuno, M; Suzuki, Y, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okuno, M | 1 |
| Akita, K | 1 |
| Moriwaki, H | 1 |
| Kawada, N | 1 |
| Ikeda, K | 1 |
| Kaneda, K | 1 |
| Suzuki, Y | 1 |
| Kojima, S | 1 |
1 other study available for gabexate and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
Topics: Animals; Cells, Cultured; Esters; Fibrinolysin; Gabexate; Guanidines; Liver Cirrhosis, Experimental; | 2001 |